CSIG-14. PTEN AS A SIGNATURE OF VULNERABILITY OF GBM TO NEDDYLATION INHIBITION
Brett Taylor(Translational Genomics Research Institute), Michael E. Berens(Translational Genomics Research Institute), Harshil Dhruv(Arysta LifeScience (France)), Nanyun Tang(Translational Genomics Research Institute), George Reid(European Molecular Biology Laboratory), Ritin Sharma(Translational Genomics Research Institute), Alison D. Parisian(University of California San Diego), Krystine Garcia‐Mansfield(Translational Genomics Research Institute), Patrick Pirrotte(Translational Genomics Research Institute), Shayesteh R. Ferdosi(Translational Genomics Research Institute), Rita Bybee(Translational Genomics Research Institute), Sen Peng(Translational Genomics Research Institute), Matthew Lee(Translational Genomics Research Institute), Jianhui Ma(Arena Pharmaceuticals (United States)), Lauren Hartman(Translational Genomics Research Institute), Frank Furnari(University of California San Diego)
Cited by 0
Related Papers
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
|Cancer Discovery|2022|277
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
|Nature Communications|2019|199
EphB2/R-Ras Signaling Regulates Glioma Cell Adhesion, Growth, and Invasion
|American Journal Of Pathology|2005|155